Intelligence · Clinical Development
Pipeline search results
Programs matching “mitoxantrone hydrochloride” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 7 pipeline programs matching "mitoxantrone hydrochloride" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Mitoxantrone Hydrochloride Liposome
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia (AML)
1 trial -
Mitoxantrone Hydrochloride Liposome
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diffuse Large B-cell Lymphoma
1 trial -
mitoxantrone hydrochloride liposome
The First People's Hospital of Lianyungang
Relapsed/Refractory Acute Myeloid Leukaemia
2 trials -
Liposomal Mitoxantrone Hydrochloride dose level 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non Hodgkin Lymphoma
1 trial -
mitoxantrone hydrochloride
Karyopharm Therapeutics Inc
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Mitoxantrone hydrochloride liposome injection30mg/m2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.